Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum.

Julie Goossens Alba Cervantes González Nele Dewit Laia Lidón Juan Fortea Daniel Alcolea Alberto Lleó Olivia Belbin Eugeen Vanmechelen

Published in: Alzheimer's research & therapy (2023)

Our novel digital immunoassay accurately measures VAMP-2 changes in CSF, which reflect AD biomarkers and cognitive performance across multiple domains.

Keyphrases

cerebrospinal fluid
late onset
cognitive decline
protein protein
sensitive detection
amyotrophic lateral sclerosis
amino acid